Nuclear Receptor Ligands in Flavivirus Infection Control-Reference-Cited by-同舟云学术

Nuclear Receptor Ligands in Flavivirus Infection Control

Published:2021 Issue: Volume: Page:483-502
ISSN:
Container-title:Nuclear Receptors
language:
Short-container-title:

Author:

El Adl Salma,Badawi Alaa

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-78315-0_18

Reference73 articles.

1. Lindenbach BD, Thiel H-J, Rice CM. Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. 5th ed. Philadelphia: Lippincott-Raven Publishers; 2007. p. 1101–52.

2. Hanley KA, Monath TP, Weaver SC, Rossi SL, Richman RL, Vasilakis N. Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol. 2013;19:292–311. https://doi.org/10.1016/j.meegid.2013.03.008. PMID: 23523817.

3. Puerta-Guardo H, Medina F, De la Cruz Henández SI, Rosales VH, Ludert JE, del Angel RM. The 1α,25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytes. Antivir Res. 2012;94(1):57–61.

4. Pereria A, de Siqueira T, Prado A, da Silva C, Moraes T, Aleixo A, de Magalhaes J, de Souza GA, Drumond BP, Ferreira GP, et al. High prevalence of dengue antibodies and the arginine variant of the FcγRIIa polymorphism in asymptomatic individuals in a population of Minas Gerais State, Southeast Brazil. Immunogenetics. 2018;70:355–62. https://doi.org/10.1007/s00251-017-1046-y.

5. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X. Chikungunya in the Americas. Lancet. 2014;383:514.